Joe L. Mills, Jr. v. Michael J. Astrue

226 F. App'x 926
CourtCourt of Appeals for the Eleventh Circuit
DecidedApril 3, 2007
Docket06-12813
StatusUnpublished
Cited by23 cases

This text of 226 F. App'x 926 (Joe L. Mills, Jr. v. Michael J. Astrue) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Joe L. Mills, Jr. v. Michael J. Astrue, 226 F. App'x 926 (11th Cir. 2007).

Opinion

PER CURIAM:

Joe Mills, Jr. appeals the district court’s order affirming the Commissioner’s denial of his application for disability insurance benefits and for supplemental security income benefits under 42 U.S.C. §§ 405(g) and 1383(c)(3). Mills argues that the administrative law judge (“ALJ”) erred in rejecting without good cause the opinion of his treating psychiatrist, Dr. Ramon Enrique Pino.

BACKGROUND

Mills applied for disability insurance benefits and for supplemental security income benefits, alleging a disability onset date of January 6, 1999 due to a compressed disc in his lower back with a post-surgical defect, sacroiliac joint dysfunction, lower back pain with radiation to lower buttock and leg, anxiety, and depression. The ALJ denied the applications, and the Appeals Council denied Mills’ request for review. Mills sought review from the district court. The magistrate judge issued its report and neither party filed any objections. The district court entered an order adopting the magistrate judge’s report and affirming the Commissioner’s decision to deny benefits.

The relevant details of Mills’ psychiatric treatment are as follows. Mills received treatment from psychiatrist Dr. Raymond Pino, following his admission to Shands Hospital for depression and for suicidal ideation on August 30, 1998. At discharge on September 5, 1998, Mills’ condition had improved and his depression was “under control” according to Pino’s discharge summary. Pino diagnosed Mills with “a major depressive disorder, recurrent, with suicidal ideas” and prescribed medications for Mills, including Effexor to treat depression.

In April 1999, Mills saw neurologist Dr. Efrain Salgado for injuries sustained in a fall. At that time, Mills reported having discontinued the psychotropic medications prescribed by Dr. Pino out of fear of mixing medications. He also reported no recurrent problems with depression. Dr. Salgado referred Mills to Dr. Rigoberto Puente-Guzman of Rehabilitation Medicine Associates for pain Mills was experiencing in his lower back.

At Mills’ initial visit to Dr. Puente-Guzman on May 12, 1999, the doctor placed him on sedentary, light level activity and warned him to avoid climbing or repetitive bending or stopping. Mills continued treatment with Dr. Puente-Guzman throughout the summer and on November 1, 1999, Dr. Puente-Guzman determined *928 Mills had reached Maximum Medical Improvement (“MMI”) with a permanent impairment rating of 7.0%.

When Dr. Puente-Guzman examined Mills on December 6, 1999, Mills reported that his pain had worsened and he was having trouble with depression, anxiety, and anger. The doctor’s notes indicate that Mills underwent a Functional Capacity Evaluation on November 17, 1999 which showed that he could perform medium category work. Dr. Puente-Guzman recommended a psychological consultation. He repeated this recommendation when Mills returned on February 9, 2000 complaining of lower back pain and numbness.

On March 13, 2000, Mills saw Dr. Michael Amiel, a psychiatrist, for depression and anxiety. Dr. Amiel determined that Mills suffered from a mood disorder partially caused by the work injury in January 1999. Amiel found that Mills’ global assessment functioning (“GAF”) score was 60 and, although not at MMI, he did not present any significant psychiatric restrictions. He recommended Mills attend weekly psychotherapy for three months.

Mills received a psychiatric review with accompanying mental residual function capacity assessment (“MRFC”) on June 19, 2000. The MRFC indicated that Mills displayed characteristics of an affective disorder and somatoform disorder. The assessment showed a slight functional limitation in Mills’ daily living activities and his maintenance of social functioning. It further indicated moderate limitations in his ability to carry out detailed instructions, maintain attention and concentration for extended periods, complete a normal workday and workweek without interruptions from psychological symptoms, and to accept instructions and respond criticism from supervisors.

Beginning July 14, 2000, Mills attended psychotherapy sessions with Dr. Paula Lovett. At the initial interview, Dr. Lovett performed several psychological tests. She diagnosed Mills as “experiencing a depressive disorder; NOS [not otherwise specified],” and “a pain disorder associated with both psychological factors and a general medical condition.” She noted that this was directly related to his work injury in January 1999. She further indicated a GAF of 60, but withheld prognosis pending treatment.

On August 21, 2000, Mills asked Dr. Puente-Guzman for a trial of antidepressant medication because of problems with his mood. He attend two more psychotherapy sessions with Dr. Lovett on September 8th and September 11th. On October 2, 2000, Mills reported to Dr. PuenteGuzman that his condition was “overall stable.”

A second residual functioning capacity assessment and MRFC were completed on October 17, 2000. The MRFC concluded that Mills was moderately limited in his abilities to maintain socially appropriate behavior, get along with coworkers, and sustain concentration to complete a normal workday and workweek.

Dr. Pino saw Mills on March 27, 2001 and determined his GAF score was 71. His notes indicate that Mills was oriented and that there was no evidence of cognitive deficits. Additionally, Mills had no current suicidal ideas and his judgment and insight were good. On April 24, 2001, Dr. Pino determined that Mills’ GAF remained at 71.

On May 22, 2001, Dr. Pino noted that Mills had reached MMI but he needed to continue therapy to treat his illness, to attempt to alleviate his suffering, and to prevent suicidal depressive relapse. Dr. Pino recommended outpatient, individual bio-psycho-social therapy. He determined that Mills’ GAF remained at 71.

*929 On May 23, 2001, Dr. Pino administered a MMI, Evaluation of Psychiatric Impairment, and concluded that Mills’ psychiatric impairment rating was 12% and that his GAF was 41. The evaluation indicated no intellectual impairment, a severe deficit in thinking, a poor significant deficit in judgment, and severe mood and behavioral problems. Dr Pino’s evaluation also indicated that Mills had plateaued in his treatment and that he had poor improvement potential.

Mills was readmitted to the hospital on July 27, 2001 for depression after he told his wife he planned to commit suicide. Mills complained of nightmares and visual and auditory hallucinations. Mills was diagnosed with, and treated for, depression and suicidal ideation, and he was released the following day.

On August 1, 2001, Mills saw Dr. Puente-Guzman and denied that he would ever kill himself. The doctor concluded that Mills should continue “with full-time, sedentary to light duty restrictions.” On August 15, 2001, Mills saw Dr. Pino who determined that Mills had reached MMI, but still needed therapy to alleviate suffering and prevent relapse. Mills’ GAF remained at 41. Dr. Pino recommended outpatient, individual therapy.

Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
226 F. App'x 926, Counsel Stack Legal Research, https://law.counselstack.com/opinion/joe-l-mills-jr-v-michael-j-astrue-ca11-2007.